QUESTLAB

Quest Laboratories Limited

Listed company · ISIN INE0TNW01017 · NSE SM · FV ₹10
Last price
₹92
-8.33%today
What this company does

Quest Laboratories Limited is a listed company. It booked ₹112 cr of revenue in its latest year (FY26) and kept 13.4% of sales as profit.

65out of 100
Equitytale Health Score
Solid

Healthier than 65% of listed companies we score, on the 5 of 6 measures we could read for it. Each measure is ranked against the 2,334–2,885 companies that reported it.

Measures financial condition, not whether to buy. Learn what this score means · How this is calculated

Price momentum
neutral
RSI (14)
68

At close. Not part of the score.

Profitability & returns68

How much profit it earns on the money it employs

Balance sheet75

How much it owes, and whether earnings cover the interest

Cash quality19

Whether reported profit actually arrives as cash

Valuation71

What today's price implies, against our models or its peers

Governance & risk100

How much of the promoters' stake is pledged, and how much they hold · highest in its sector on what we could measure

Not measurable for this company: growth & consistency. Those pillars are left out of the score rather than counted as zero.

Is this company doing well?
not investment advice
Looks broadly healthy
Strengths
✓ Makes a profit
✓ Promoters hold 67%
✓ No promoter shares pledged
✓ Strong 16% return on equity
✓ Virtually debt-free
Watch-outs
None flagged from our data

What if I invest in QUESTLAB?

Set a growth rate and see what a monthly SIP would add up to. Your assumption, our arithmetic.

You would put in
₹12.00 lakh
120 instalments
At 10% a year, it would become
₹20.15 lakh

The starting rate is a round number, not a view on this company — this is your assumption, and the figure above is arithmetic on it. Returns are not steady year to year, and a real holding would not grow in a straight line. We do not publish price targets or predict returns.

Key ratios · latest full year + price
₹92▼ -8.33%
latest close · 2026-10-01
52-wk low ₹6950 sessions so far52-wk high ₹102
Is it cheap or expensive?
What you pay for the profits, book value and cash flow. Higher isn't automatically worse — it can signal faster growth.
P/E ratio10.0Low
LowAverageHigh
P/B ratio1.55Moderate
Below bookModerateHigh
EV / EBITDA7.6Low
LowAverageHigh
How good is the business?
How much profit it earns from its money and its sales.
Return on equity15.5%Strong
WeakFairStrong ▸15%
Return on capital20.2%Strong
WeakFairStrong
Net margin13.4%Decent
ThinDecentStrong
EBITDA margin18.6%Decent
ThinDecentHealthy
Is it financially safe?
How much it owes, and whether it can comfortably cover it.
Debt to equity0.08Comfortable
LowModerateHigh ▸1
Interest cover10.8×Strong
RiskyOkayStrong ▸5×
Current ratio7.31Ample
Tight ◂1HealthyAmple
More figures
Market cap
₹151 cr
Book value
₹59
EPS
₹9.16
latest full year
Net debt
₹8 cr
owes more than its cash
Enterprise value
₹158 cr
EBITDA
₹21 cr
latest full year
EBIT
₹20 cr
latest full year
Operating margin
17.9%
Return on assets
13.5%
Earnings yield
9.97%
P/S
1.35
Sales / share
₹68.2
Tax rate
17.1%
Face value
₹10
Shares
1.6 cr
Working capital
₹79 cr
Current assets
₹92 cr
Current liabilities
₹13 cr
Delivery %
82.9%
Strong / safeFairWeak / riskyValuation — a level, not good/badBands are general rules of thumb, not advice.

P/E, ROE, ROCE and margins are from the latest full-year results; per-share and balance-sheet ratios use the most recent balance sheet on file · prices as of 2026-10-01.

Worth vs price · from the exchange filings
not investment advice
Hard to value confidentlyLow confidence
Too few reliable models — the filings don't support two independent estimates of value.
Models span ₹68–₹68, midpoint ₹68

An educational model from the company's own filings, every assumption shown — not investment advice or a price target. Prices can stay above or below any model for years.

P&L · FY26 (consolidated)
Revenue from Operations₹112 cr
Other Income₹3 cr
Total Income₹114 cr
Cost of Materials₹92 cr
Purchases of Stock-in-Trade₹0 cr
Inventory Change (±)₹-5 cr
Employee Benefit Expense₹5 cr
Finance Costs₹2 cr
Depreciation & Amortisation₹82.5 L
Other Expenses₹2 cr
Total Expenses₹96 cr
Profit before Tax₹18 cr
Tax Expense₹3 cr
Net Profit₹15 cr
Net margin on total income13.1%
Where the money goes · FY26
% of total income
Materials + stock-in-trade₹86 cr75.5%
Employee benefit expense₹5 cr4.2%
Finance costs₹2 cr1.6%
Depreciation & amortisation₹82.5 L0.7%
Other expenses₹2 cr2.2%
Tax expense₹3 cr2.7%
Profit for the period₹15 cr13.1%
Total income ₹114 cradds up to ₹100 ✓
Quarterly results · consolidated (₹ cr)
MetricQ1 FY26Q3 FY26
Revenue23 cr31 cr
Total income25 cr31 cr
Expenses20 cr24 cr
Profit before tax5 cr7 cr
Tax72 L3 cr
Net profit (owners' share)4 cr4 cr
Net margin (owners' share, on revenue)17.7%13.2%
EPS (₹)2.502.46
Balance sheet & cash flow · as of Mar 2026
Low debt
Total assets
₹111 cr
Shareholder equity
₹97 cr
parent shareholders
Total debt
₹8 cr
Cash
₹10.5 L
Who owns it · 2026-03-31
No pledge
Promoter
66.8%
FII / Foreign
0.6%
DII / Domestic
2.0%
Retail / others
30.6%
Promoter stake up 0.6% over the last 4 quarters.
Smart-money activity
Bulk / block deals
BoughtYASHVI HITESH PATEL · NSE1.01 L @ ₹97.8730 Sep 26
BoughtINVICTO MULTIPLIER FUND · NSE1.70 L @ ₹8827 Aug 26
SoldBHAVNA HITESH PATEL · NSE99,600 @ ₹8827 Aug 26
Who controls this company, and what it pays them

Most Indian companies are controlled by a family or group — the promoters. The exchange requires them to be listed by name, including members who own no shares at all, and requires the company to disclose any business it does with them.

The promoter group — 3 named members
owning 66.8% between them · as of 2026-03-31
ANIL KUMAR SABARWAL62.80%
TEJASWINI SABARWAL2.59%
VINAYAK SABARWAL1.40%

Names and holdings from the company’s shareholding pattern filed with the exchange; transactions from the related-party note in its annual report. Every figure is as filed — these are legal, disclosed dealings, and what to make of them is your call.

How the stock has moved · adjusted for splits & bonuses
Data from primary exchange filings · analysis tool, not investment advice.